Novo Nordisk has agreed to buy Akero Therapeutics and its drug candidate for metabolic dysfunction-associated steatohepatitis (MASH) for $4.7 billion upfront, shortly after claiming FDA approval to ...
Mommy Poppins on MSN
Halloween, Children's Theater, and More Things To Do in Chicago This Weekend With Kids
Looking for the best things to do in Chicago this weekend? Here are some family-friendly events and activities to add to your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback